... CvnCoV vaccine , belonging to the German biotechnology company CureVac NV, it was discovered that the injection has an efficacy of 47 percent, ...
News
- Curevac NV vaccine disappoints with results in late-stage trial
- Pandemic-delayed surgeries share blame for blood shortage
William DeSisto, a professor of chemical and biomedical engineering, worked with distillers around the state to get ethanol to make the sanitizer early ...
- Team describes science-based hiccups intervention
The University of Texas Health Science Center at San Antonio, also ... nursing, dentistry, health professions and graduate biomedical sciences have ...
- 'We can't let this happen again,' bill to form agency proposed to stop next pandemic
SAN ANTONIO - After the most catastrophic year and a half, lawmakers and ... State Senator Jose Menendez worked with Dr. Larry Schlesinger, President and CEO of Texas Biomedical Research Institute, to propose Senate Bill 264.
- India says it hopes to resume vaccine exports
... roadmap that depends on India's two main suppliers -- Serum Institute and Bharat Biotech -- ramping up production and five other potential vaccines ...